Sarepta Therapeutics: Funding, Investors & Team (Sep 2026)
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.
Sarepta Therapeutics has raised $506M across 2 funding rounds on record, the most recent a Post-IPO Equity of $6.0M announced in Sep 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sarepta Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Sarepta Therapeutics Funding Rounds
Sarepta Therapeutics raised $500M in a Post-IPO Equity announced in Oct 2021.
11 months later, a Post-IPO Equity of $6.0M was announced in Sep 2022.
Sarepta Therapeutics Founders and Leadership Team
Contact details for the Sarepta Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Sarepta Therapeutics Funding Compared to Other Biotechnology Startups
Sarepta Therapeutics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sarepta Therapeutics in Biotechnology and Cambridge
Companies Similar to Sarepta Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sarepta Therapeutics Funding FAQs
What does Sarepta Therapeutics do?
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.
How much funding has Sarepta Therapeutics raised?
Sarepta Therapeutics has raised $506M across 2 rounds on record. The most recent is a Post-IPO Equity of $6.0M announced in Sep 2022.
When did Sarepta Therapeutics last raise funding?
Sarepta Therapeutics' most recent funding round on record is a Post-IPO Equity of $6.0M, announced in Sep 2022.
Who is the CEO of Sarepta Therapeutics?
Douglas S Ingram is listed as CEO at Sarepta Therapeutics.
Where is Sarepta Therapeutics headquartered?
Sarepta Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Sarepta Therapeutics have?
Sarepta Therapeutics is in the 501-1000 employee band.
How does Sarepta Therapeutics' funding compare to other Biotechnology startups?
Sarepta Therapeutics' latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sarepta Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sarepta Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.